Hyperion Therapeutics (HPTX) Files $57.5M IPO

April 13, 2012 6:46 AM EDT
Get Alerts HPTX Hot Sheet
Trade HPTX Now!
Join SI Premium – FREE
Hyperion Therapeutics (Nasdaq: HPTX) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $57.5 million. Hyperion plans to list on the Nasdaq Global Market under the ticker "HPTX."

The offering is being made through Leerink Swann, Cowen and Company, and Needham & Company.

Hyperion is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Needham & Company, Cowen & Co

Add Your Comment